TY - JOUR
T1 - RADIATION DOSE FOR PATIENTS WITH KAWASAKI DISEASE UNDERGOING FLUOROSCOPICALLY GUIDED CARDIAC CATHETERIZATION
AU - Miranda, Patricia
AU - Vano, Eliseo
AU - Ubeda, Carlos
AU - Figueroa, Ximena
AU - Doggenweiller, Paulina
AU - Oliveira, Marcus
AU - Dalmazzo, Dandaro
N1 - Publisher Copyright:
© 2022 The Author(s).
PY - 2021/12/1
Y1 - 2021/12/1
N2 - The goal of the present study was to estimate the radiation dose for a group of 45 Kawasaki disease (KD) patients undergoing fluoroscopically guided cardiac catheterization. The sample of procedures corresponds to a single hospital and was collected in 10 years. Anthropometric characteristics and the quantities of air kerma-area product (PKA) among others were recorded for each procedure. Monte Carlo PCXMC 2.0 software was used to estimate organ and effective doses. The PKA value of 7.2 Gy cm2 was proposed as the local Diagnostic Reference Level for KD. For organ absorbed doses, median values for thyroid, heart, lungs, esophagus, skin, active bone and breast were 1.2; 2.2; 4.6; 2.7; 1.1; 1.2 and 2.7 mGy, respectively. For effective dose, the mean value was 2.7 ± 2.5 mSv. This paper presents the first patient dose values for the KD using catheterization techniques, in Latin America and the Caribbean Region.
AB - The goal of the present study was to estimate the radiation dose for a group of 45 Kawasaki disease (KD) patients undergoing fluoroscopically guided cardiac catheterization. The sample of procedures corresponds to a single hospital and was collected in 10 years. Anthropometric characteristics and the quantities of air kerma-area product (PKA) among others were recorded for each procedure. Monte Carlo PCXMC 2.0 software was used to estimate organ and effective doses. The PKA value of 7.2 Gy cm2 was proposed as the local Diagnostic Reference Level for KD. For organ absorbed doses, median values for thyroid, heart, lungs, esophagus, skin, active bone and breast were 1.2; 2.2; 4.6; 2.7; 1.1; 1.2 and 2.7 mGy, respectively. For effective dose, the mean value was 2.7 ± 2.5 mSv. This paper presents the first patient dose values for the KD using catheterization techniques, in Latin America and the Caribbean Region.
UR - https://www.scopus.com/pages/publications/85123968852
U2 - 10.1093/rpd/ncab182
DO - 10.1093/rpd/ncab182
M3 - Article
C2 - 34979032
AN - SCOPUS:85123968852
SN - 0144-8420
VL - 197
SP - 230
EP - 236
JO - Radiation Protection Dosimetry
JF - Radiation Protection Dosimetry
IS - 3-4
ER -
